From the Departments of Psychiatry (K.Y., A.L.B.), Neurology (K.Y.), and Epidemiology (K.Y.), University of California, San Francisco; San Francisco VA Medical Center (K.Y.); Northern California Institute Research for Research and Education (T.D.H.), San Francisco; University of Massachusetts School of Medicine (S.F.), Worchester; School of Public Health (D.R.J.), University of Minnesota, Minneapolis; School of Public Health (C.E.L.), University of Alabama at Birmingham; Northwestern University Feinberg School of Medicine (D.M.L.-J.), Chicago, IL; Division of Research (S.S.), Kaiser Permanente Northern California, Oakland; and National Heart, Lung, and Blood Institute (J.R.), Bethesda, MD.
Neurology. 2020 Aug 18;95(7):e839-e846. doi: 10.1212/WNL.0000000000010078. Epub 2020 Jul 15.
Increasing evidence supports an association between midlife cardiovascular risk factors (CVRFs) and risk of dementia, but less is known about whether CVRFs influence cognition in midlife. We examined the relationship between CVRFs and midlife cognitive decline.
In 2,675 black and white middle-aged adults (mean age 50.2 ± 3.6 years, 57% female, 45% black), we measured CVRFs at baseline: hypertension (31%), diabetes mellitus (11%), obesity (43%), high cholesterol (9%), and current cigarette smoking (15%). We administered cognitive tests of memory, executive function, and processing speed at baseline and 5 years later. Using logistic regression, we estimated the association of CVRFs with accelerated cognitive decline (race-specific decline ≥1.5 SD from the mean change) on a composite cognitive score.
Five percent (n = 143) of participants had accelerated cognitive decline over 5 years. Smoking, hypertension, and diabetes mellitus were associated with an increased likelihood of accelerated decline after multivariable adjustment (adjusted odds ratio [AOR] 1.65, 95% confidence interval [CI] 1.00-2.71; AOR 1.87, 95% CI 1.26-2.75; AOR 2.45, 95% CI 1.54-3.88, respectively), while obesity and high cholesterol were not associated with risk of decline. These results were similar when stratified by race. The likelihood of accelerated decline also increased with greater number of CVRFs (1-2 CVRFs: AOR 1.77, 95% CI 1.02-3.05; ≥3 CVRFs: AOR 2.94, 95% CI 1.64-5.28) and with Framingham Coronary Heart Disease Risk Score ≥10 (AOR 2.29, 95% CI 1.21-4.34).
Midlife CVRFs, especially hypertension, diabetes mellitus, and smoking, are common and associated with accelerated cognitive decline at midlife. These results identify potential modifiable targets to prevent midlife cognitive decline and highlight the need for a life course approach to cognitive function and aging.
越来越多的证据表明,中年心血管危险因素(CVRFs)与痴呆风险之间存在关联,但对于 CVRFs 是否会影响中年认知功能知之甚少。我们研究了 CVRFs 与中年认知衰退之间的关系。
在 2675 名黑人和白人中年成年人(平均年龄 50.2 ± 3.6 岁,57%为女性,45%为黑人)中,我们在基线时测量了 CVRFs:高血压(31%)、糖尿病(11%)、肥胖症(43%)、高胆固醇血症(9%)和当前吸烟(15%)。我们在基线和 5 年后进行了记忆、执行功能和处理速度的认知测试。使用逻辑回归,我们根据种族特异性变化(从平均变化的 1.5 SD 以上)对复合认知评分估计了 CVRFs 与加速认知衰退的关联。
在 5 年内,有 5%(n = 143)的参与者认知衰退加速。经过多变量调整后,吸烟、高血压和糖尿病与加速下降的可能性增加相关(调整后的优势比[AOR] 1.65,95%置信区间[CI] 1.00-2.71;AOR 1.87,95% CI 1.26-2.75;AOR 2.45,95% CI 1.54-3.88),而肥胖症和高胆固醇血症与下降风险无关。当按种族分层时,这些结果相似。随着 CVRFs 数量的增加(1-2 个 CVRFs:AOR 1.77,95% CI 1.02-3.05;≥3 个 CVRFs:AOR 2.94,95% CI 1.64-5.28)和 Framingham 冠心病风险评分≥10(AOR 2.29,95% CI 1.21-4.34),加速下降的可能性也会增加。
中年 CVRFs,尤其是高血压、糖尿病和吸烟,较为常见,并与中年加速认知衰退有关。这些结果确定了潜在的可改变目标,以预防中年认知衰退,并强调需要采取一种生命历程方法来研究认知功能和衰老。